Is stem cell therapy for Back Pain & Disc Degeneration FDA-approved?
The FDA consumer alert states that the promoted stem-cell and exosome products it addresses are not approved for disc disease or back pain. Device clearance, imaging guidance or autologous sourcing is not product approval.
How stem cells are studied for Back Pain & Disc Degeneration
Back pain is a symptom with muscular, joint, disc, nerve, inflammatory, fracture, infection, cancer and visceral causes. Intradiscal, epidural, facet, paraspinal or intravenous cell and exosome procedures have different targets and risks. A disc-regeneration mechanism in a laboratory does not establish pain relief, neurological recovery or avoidance of surgery.
Am I a candidate? → · Back Pain & Disc Degeneration: full overview → · Back Pain & Disc Degeneration cost → · Cost →
Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.
Sources & further reading
More on this condition
- Back Pain & Disc Degeneration: cell-therapy evidence and registered trials
- How much does stem cell therapy for Back Pain & Disc Degeneration cost? (2026)
- Back Pain & Disc Degeneration stem cell therapy — your questions answered (2026)
- Back Pain & Disc Degeneration: cell-therapy evidence by therapy class